A probabilistic assessment of the impact of interventions on oncology nurses' exposure to antineoplastic agents

Occupational and Environmental Medicine

Volumn 63, Issue 8, 2006, Pages 530-537

  Meijster, T ^a,b   Fransman, W ^c   Van Hemmen, J ^a   Kromhout, H ^c   Heederik, D ^c   Tielemans, E ^a  

^a TNO   (Netherlands)

^b Risk Assessment in the Work Environment   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE;

CONTROLLED STUDY; HEALTH CARE POLICY; HUMAN; INCIDENCE; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; NURSE; OCCUPATIONAL EXPOSURE; ONCOLOGY; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; PROTECTIVE CLOTHING; REVIEW; STATISTICAL ANALYSIS; URINE;

ANTINEOPLASTIC AGENTS; HEALTH POLICY; HUMANS; MONTE CARLO METHOD; NETHERLANDS; OCCUPATIONAL EXPOSURE; ONCOLOGIC NURSING; PROBABILITY; SKIN;

EID: 33746579734     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2005.022723     Document Type: Review

References (34)

1. Vermeulen R, de Hartog J, Swuste P, et al. Trends in exposure to inhalable participate and dermal contamination in the rubber manufacturing industry: effectiveness of control measures implemented over a nine-year period. Ann Occup Hyg 2000;44:343-54.
2. Burstyn I, Kromhout H, Cruise PJ, et al. Designing an international industrial hygiene database of exposures among workers in the asphalt industry. Ann Occup Hyg 2000;44:57-66.
3. Burstyn I, Kromhout H. Trends in inhalation exposure to hydrocarbons among commercial painters in The Netherlands. Scand J Work Environ Health 2002;28:429-38.
4. van Tongeren MJ, Kromhout H, Gardiner K. Trends in levels of inhalable dust exposure, exceedance and overexposure in the European carbon black manufacturing industry. Ann Occup Hyg 2000;44:271-80.
5. Symanski E, Chang CC, Chan W. Long-term trends in exposures to nickel aerosols. AIHAJ 2000;61:324-33.
6. Okun A, Cooper G, Bailer AJ, et al. Trends in occupational lead exposure since the 1978 OSHA lead standard. Am J Ind Med 2004;45:558-72.
7. Kromhout H, Vermeulen R. Long-term trends in occupational exposure: Are they real? What causes them? What shall we do with them? Ann Occup Hyg 2000;44:325-7.
8. Symanski E, Kupper LL, Rappaport SM. Comprehensive evaluation of long-term trends in occupational exposure: Part 1. Description of the database. Occup Environ Med 1998;55:300-9.
9. Goldenhar LM, Schulte PA. Intervention research in occupational health and safety. J Occup Med 1994;36:763-75.
10. Goldenhar LM, Schulte PA. Methodological issues for intervention research in occupational health and safety. Am J Ind Med 1996;29:289-94.
11. Zwerling C, Daltroy LH, Fine U, et al. Design and conduct of occupational injury intervention studies: a review of evaluation strategies. Am J Ind Med 1997;32:164-79.
12. Roelofs CR, Barbeau EM, Ellenbecker MJ, et al. Prevention strategies in industrial hygiene: a critical literature review. AIHA J (Fairfax, Va) 2003;64:62-7.
13. Brosseau LM, Parker DL, Lazovich D, et al. Designing intervention effectiveness studies for occupational health and safety: The Minnesota Wood Dust Study. Am J Ind Med 2002;41:54-61.
14. Lazovich D, Parker DL, Brosseau LM, et al. Effectiveness of a worksite intervention to reduce an occupational exposure: the Minnesota wood dust study. Am J Public Health 2002;92:1498-505.
15. Lazovich D, Murray DM, Brosseau LM, et al. Sample size considerations for studies of intervention efficacy in the occupational setting. Ann Occup Hyg 2002;46:219-27.
16. SZW. Occupational health and safety covenants: just what we need. The Hague: Ministry of Social Affairs and Employment, 2004.
17. Cullen AC, Frey HC. Probabilistic techniques in exposure assessment: a handbook for dealing with variability and uncertainty in models and inputs. New York: Plenum Press, 1999.
18. Sessink PJ, Boer KA, Scheefhals AP, et al. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers. Int Arch Occup Environ Health 1992;64:105-12.
19. Sessink PJ, Bos RP, Kerkhof MCA, et al. Environmental contamination and Assessment of exposure to antineoplastic agents by determination of cyclophosphamide in urine of exposed pharmacy technicians: Is skin absorption an important exposure route. Arch environ health 1994;49:165-9.
20. Sessink PJ, Wittenhorst BCJ, Anzion RBM, et al. Exposure of pharmacy technicians to antineoplastic agents after additional protective measures. Arch Environ Health 1997;52:240-4.
21. Peelen S, Roeleveld N, Heederik D, et al. Reproductie toxische effecten bij ziekenhuispersoneel. Den Haag: Ministerie van Sociale Zaken en Werkgelegenheid, 1999.
22. Kromhout H, Hoek F, Uitterhoeve R, et al. Postulating a dermal pathway for exposure to antineoplastic drugs among hospital workers. Applying a conceptual model to the result of three workplace surveys. Ann Occup Hyg 2000;44:551-60.
23. Fransman W, Vermeulen R, Kromhout H. Occupational dermal exposure to cyclophosphamide in Dutch hospitals: a pilot study. Ann Occup Hyg 2004;48:237-44.
24. Fransman W, Vermeulen R, Kromhout H. Dermal exposure to cyclophosphamide in hospitals during preparation, nursing and cleaning activities. Int Arch Occup Environ Health 2005;78:403-12.
25. Vose D. Risk analysis: a quantitative guide. New York: John Wiley and Sons, 2000.
26. Frey HC, Burmaster DE. Methods for characterizing variability and uncertainty: comparison of bootstrap simulation and likelihood-based approaches. Risk Anal 1999;19:109-30.
27. Zhao Y, Frey HC. Quantification of variability and uncertainty for censored data sets and application to air toxic emission factors. Risk Anal 2004;24:1019-34.
28. Hamey PY. An example to illustrate the potential use of probabilistic modelling to estimate operator exposure to pesticides. Ann Occup Hyg 2001;45(Suppl 1):55-64.
29. Sessink PJM, Anzion RBM, Broek PHHvd, et al. Detection of contamination with anti-neoplastic agents in a hospital pharmacy department. Pharm Weekabl Sci 1992;14:16-22.
30. Sessink PJM. Monitoring of occupational exposure to antineoplastic agents. Nijmegen: University of Nijmegen, 1996.
31. Turci R, Sottani C, Ronchi A, et al. Biological monitoring of hospital personnel occupationally exposed to antineoplastic agents. Toxicol Lett 2002;134:57-64.
32. Keenan RE, Finley BL, Price PS. Exposure assessment: then, now, and quantum leaps in the future. Risk Anal 1994;14:225-30.
33. Cox LA Jr. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis. Environ Health Perspect 1996;104(Suppl 6):1413-29.
34. Semple S, Proud LA, Cherrie JW. Use of Monte Carlo simulations to investigate uncertainty in exposure modeling. Scand J Work Environ Health 2003;29:347-53.